Back2sleep.euCurrent Status
Unclaimed
Anti-Snoring Solution
What is back2sleep.eu?
Back2Sleep offers an anti-snoring solution and medical device designed to address sleep apnea and snoring. Their nasal stent aims to improve sleep quality and reduce the risks associated with sleep disorders. They have a starter kit and subscription options.
Recent user report trends for back2sleep.eu
Aggregated user reports in the last 48 hours.
Experiencing issues? Check the full status page to see detailed history and report a problem.
View full status pageSite health
88%
Performance
66
Accessibility
91
Best Practices
96
SEO
100
Avg. health score by country
Hover over a country for details from the last test run.
United States
84
Germany
84
Singapore
87
Australia
88
South Africa
88
Brazil
86
Technologies used
More Details About Back2sleep
Starter Kit
Offers a starter kit with four different lengths to ensure a comfortable and effective fit for first-time users, addressing the variability in individual nasal passages.
Subscription Solution
Provides a simple, efficient, and economical monthly subscription service, ensuring consistent access to the Back2Sleep nasal stent for regular users.
Clinically Proven
Demonstrates scientifically proven results through clinical data, showing a confirmed decrease in the apnea-hypopnea score and improvement in oxygen saturation index.
Meet our customers
"“Understanding Snoring and How to Address It” by Professor Chabolle Professor Chabolle is a world-renowned ENT (Ear, Nose, Throat) specialist. He explains the causes of snoring and sleep apnea, as well as the mechanism of action of Back2Sleep. The explanation is in French with English subtitles."
Anonymous
- Intranasal stent reaches soft palate
- No masks or electricity required
- Simple 10-second insertion process
- Works silently throughout the night
- Low cost per night (€0.83)
- 92% user satisfaction rate
- CE Medical Device Class I certified
- Available in 57,000 pharmacies globally
- 1 million tubes sold worldwide
- Clinical study with 248 patients
- Double-blind placebo-controlled methodology
- 64% average AHI reduction
- 96%+ oxygen saturation maintained
- 85% snoring reduction reported
- Travel-friendly and TSA-compliant